Abstract
Background The Centers for Medicare & Medicaid Services (CMS) administers the Hospital Quality Improvement Contractor (HQIC) program to improve healthcare quality and safety in hospitals serving Medicare beneficiaries. These contractors provided technical assistance to small, rural hospitals, and/or to hospitals with lower quality ratings. This study aimed to evaluate the program’s effectiveness in addressing two priority areas: reducing hospital readmissions and increasing patient safety.
Methods A quasi-experimental design was used to assess the impact of HQIC support on 30-day all- cause readmissions and eight patient safety outcomes in hospitals that received support between October 1, 2020, and December 31, 2023 (N = 1,929). Patient safety outcomes included adverse drug events (ADEs) and healthcare-associated infections (HAI). A difference-in-difference model specification with a Poisson generalized estimating equation was used to compare hospitals receiving support for each outcome to matched hospitals that did not receive HQIC support.
Results Receiving HQIC support was associated with a 1.4% reduction in the number of 30-day all- cause readmissions compared to hospitals with similar characteristics that did not receive HQIC support for readmissions. Hospitals receiving HQIC support for reducing catheter-associated urinary tract infections (CAUTI) showed a 17.4% reduction in the number of CAUTI events relative to hospitals that did not receive support. There was no statistically significant effect on the other outcomes.
Conclusions The HQIC program support had an impact on reductions in hospital readmissions and reductions for one of the HAIs but not on other patient safety outcomes. These findings suggest a targeted approach in resource allocation may improve readmissions and CAUTI rates for small and rural hospitals.
What is already known on this topic
Hospital readmissions, adverse drug events in inpatient care, and healthcare-associated infections increase morbidity and mortality and are costly to the healthcare system, and evidence-based strategies exist to help reduce these events.
The Centers for Medicare & Medicaid Services implemented a national quality improvement initiative that provides training and technical assistance to hospitals, particularly to small and rural hospitals, to reduce readmissions and improve patient safety outcomes.
What this study adds
This study provides the opportunity to examine the impact of a national quality improvement effort on hospital readmissions and patient safety outcomes. Quality improvement support was associated with significant reductions in hospitals’ 30-day all-cause readmissions and catheter- associated urinary tract infections, but not with other patient safety indicators assessed.
How this study might affect research, practice or policy
The finding that quality improvement support to hospitals resulted in improved outcomes suggests the need for prioritization and investment in this approach.
The limited program impact on improving rare outcomes highlights the importance of aligning goals with the unique needs of smaller, rural hospitals in the design of future quality improvement programs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Centers for Medicare and Medicaid services (CMS) (Contract number: GS00F008DA, Task Order Number: 75FCMC20F1112). CMS provided feedback on the study design and analysis, and co-authors from CMS were involved in the writing of the manuscript. CMS made the final decision to publish.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Aggregated / summary data with no individual level data. Additionally, this study evaluates and improves a public benefit program and thereby falls under the 45 CFR 46.104(d)(5) exemption from human subjects research requirements.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Acevedo_Andrea{at}bah.com, Shang_Qingkun{at}bah.com, Gyr_Ashlie{at}bah.com, Carter_Cassandra{at}bah.com, Geoffrey.Berryman{at}cms.hhs.gov, Nancy.Sonnenfeld{at}cms.hhs.gov
Edited down on word count slightly to better match journal requirements; no significant changes
Data Availability
No data are available. Although de-identified Medicare data can be requested through the Research Data Assistance Center (ResDAC) at https://resdac.org/ with a data use agreement, hospital identity, and data collected for the study are not available due to the quality improvement nature of the work.
